GlassScriptPhysician profile
Thomas Kerestes
NPI 1922455484
$11,237.43
in general payments reported to CMS, 2019-2025
20 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $560 · 2023: $6,534 · 2024: $3,679 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,584 · Travel and Lodging: $3,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,583.58 |
| Travel and Lodging | $3,961.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $5,228.33 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Abbvie INC. | $2,354.72 | 2023-2025 | |
| Tela Bio, INC. | $1,877.21 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $445.33 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kls-Martin L.P. | $267.97 | 2021-2023 | |
| Mentor Worldwide LLC | $251.22 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Polynovo North America LLC | $210.77 | 2022 | |
| Acera Surgical, INC. | $185.62 | 2022-2023 | Restrata Wound Matrix |
| Avita Medical Americas, LLC | $114.12 | 2024 | |
| Stryker Corporation | $48.53 | 2025 | Spy-Phi System |
| Allergan, INC. | $45.33 | 2022 | |
| Kci USA, INC. | $41.24 | 2023 | |
| Depuy Synthes Sales INC. | $31.70 | 2023 | Microfix Quickanchor Ethibond |
| Smith+Nephew, INC. | $27.10 | 2024 | Grafix Pl |
| Aroa Biosurgery Incorporated | $22.91 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $18.18 | 2024 | |
| W. L. Gore & Associates, INC. | $17.99 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Organogenesis INC. | $17.07 | 2025 | Simplimax |
| Integra Lifesciences Corporation | $16.96 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Merck Sharp & Dohme LLC | $15.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kerestes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.